Overview

Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma .

Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
Multicenter prospective phase II study evaluating regorafenib in older patients with metastatic colorectal cancer
Phase:
Phase 2
Details
Lead Sponsor:
Federation Francophone de Cancerologie Digestive